Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.
about
Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinicTransplantation Tolerance Induction: Cell Therapies and Their MechanismsToward Development of iMesenchymal Stem Cells for Immunomodulatory TherapyStem cells as drug delivery methods: application of stem cell secretome for regenerationNew advances in the mesenchymal stem cells therapy against skin flaps necrosisStem Cells of Dental Origin: Current Research Trends and Key Milestones towards Clinical ApplicationModulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHDMesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterologyRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsPractical Issues with the Use of Stem Cells for Cancer Gene TherapyDynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the Severity of Collagen-Induced Experimental Arthritis.The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rateMesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Human Kidney-Derived Cells Ameliorate Acute Kidney Injury Without Engrafting into Renal TissueConcise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Biodistribution and Efficacy of Human Adipose-Derived Mesenchymal Stem Cells Following Intranodal Administration in Experimental Colitis.Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.Induction of mixed chimerism using combinatory cell-based immune modulation with mesenchymal stem cells and regulatory T cells for solid-organ transplant tolerance.MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy.Quantitative Magnetic Particle Imaging Monitors the Transplantation, Biodistribution, and Clearance of Stem Cells In VivoPhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.The effect of Kisspeptin-10 on mesenchymal stem cells migration in vitro and in vivo.Effects of immunosuppressive drugs on viability and susceptibility of adipose- and bone marrow-derived mesenchymal stem cells.Failure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat.Comparative Ability of Mesenchymal Stromal Cells from Different Tissues to Limit Neutrophil Recruitment to Inflamed EndotheliumMesenchymal Stromal Cell-Derived Factors Promote Tissue Repair in a Small-for-Size Ischemic Liver Model but Do Not Protect against Early Effects of Ischemia and Reperfusion Injury.Human Cardiac Mesenchymal Stromal Cells with CD105+CD34- Phenotype Enhance the Function of Post-Infarction Heart in Mice.Association between in vivo bone formation and ex vivo migratory capacity of human bone marrow stromal cellsA Cost-Effective Method to Assemble Biomimetic 3D Cell Culture PlatformsFate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and ResectionInhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regenerationMesenchymal stem cells: are we ready for clinical application in transplantation and tissue regeneration?Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats.Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation.Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice.Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.
P2860
Q26739745-5957139D-A1CA-4E08-B664-76FEEE1FC3AAQ26751022-1690B1F6-3018-4E1A-B3CA-86D7B4446F62Q26771451-5C0160FB-CC2D-43B2-8016-07EDFD69C010Q26862657-7E5C53BC-2615-4DD6-9A80-EC60227BBB55Q27011792-23809A81-C122-4B59-A7DE-978838E7C04FQ28073659-6F7E6F28-21DF-4DDF-8AD5-5609A7D810AAQ28077242-D7EACA48-3F2F-4C87-B51D-7FE21AC565C8Q28077427-1C21F424-6E7B-4AF2-88FA-591B230A6D53Q28079823-755F677B-6D7D-4F1F-AD9B-E860A689B0A8Q28085238-3C96824C-EBBB-4F90-BDEE-242FBE6D63A5Q30538835-3737A2AA-435F-4925-A8B4-F2E59583B3C3Q33586104-B18BA509-F25D-43B6-8CEC-8F31FFD107FBQ33608949-23F20DA6-796A-4B65-9A92-518139F46A91Q33719419-F230F0E8-8414-45D3-974C-61BF656CE62EQ33722057-066AA609-3F5E-41BA-9CA2-73B74B1CDD31Q33722466-2AF366A5-0437-41DF-B153-192B206B69D1Q33722631-DB37E24C-3BAD-4DAC-A1D4-51813C9B5947Q33774583-D395F482-0A40-4EE8-92D2-6325D5FABDBAQ33900615-0BFBBF01-B2C4-4135-B0CB-EE7C042CE52FQ34231351-37378036-7C04-4E1A-9865-9303AFFA4A8FQ34370097-0BD028CD-5C57-4674-947B-2A340E1D1655Q34515367-BEDAD37F-C8AB-4EE9-8655-8DC9DBC82AB2Q34649457-F1D08D41-358A-4478-A381-5B421D5FCED0Q35098108-C2837BE8-F854-452C-B49F-4BAA4EFD882CQ35443237-09BFD850-D86A-425B-B6E4-24B767258BD6Q35577615-7A0A47E1-0936-41CD-A768-C03E628D321BQ36015654-271A8853-1D13-47E6-9C94-CD969F02ACC4Q36031956-8FAA75FA-8337-446C-85F8-17E5E200B2ADQ36077608-C9875EEA-F387-4DCE-B1A9-A1D37F1D3192Q36141009-79336BF0-A034-4008-B3F3-FEE0C87DFEBDQ36217699-C1AD8B7A-3DBD-401A-A86F-C821BE92FCC4Q36615412-169D5A40-89BD-41A7-BE1A-7454FE164933Q36719155-F4012E8C-8105-4BF3-AF9B-3DBDC758C2ADQ36917428-0268658D-0E49-4B1F-8962-47934257E658Q37020401-C643CF74-D8F9-44D0-9684-9FBCA405DE41Q37034680-742D7606-ADD6-4D9F-92CF-F03FD7FF194CQ37050899-457B2F66-9D6C-4EB7-B9C4-E98DB97EF93AQ37052844-4FE7FE80-DFE9-4A5A-8EA5-67DFC2CA8871Q37079961-42248A04-A390-4E91-B3CD-050FE25CE5A1Q37202720-B6945506-B272-42AF-882E-41DB391AB677
P2860
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mesenchymal stem cells are sho ...... gs after intravenous infusion.
@en
type
label
Mesenchymal stem cells are sho ...... gs after intravenous infusion.
@en
prefLabel
Mesenchymal stem cells are sho ...... gs after intravenous infusion.
@en
P2093
P2860
P356
P1476
Mesenchymal stem cells are sho ...... ngs after intravenous infusion
@en
P2093
E Eggenhofer
E K Geissler
H J Schlitt
M H Dahlke
M J Hoogduijn
V Benseler
P2860
P356
10.3389/FIMMU.2012.00297
P50
P577
2012-09-26T00:00:00Z